Neovision Capital

Chengdu New Radiomedicine Technology Co.,Ltd. is a Chinese medical isotopes provider. Our business covers research, manufacture and sales for medical isotopes and products. We provide services for malignant tumor diagnosis and treatments and radionuclides medicine technology support and consulting. In April 2016, the company was founded by three co-founders experienced in radionuclides research and development. Jihui Qian, former President of Nuclear Power Institute of China (NPIC), former Deputy Director-General of International Atomic Energy Agency (IAEA); Maoliang Li, former Director of Chengdu Isotopes Institute of NPIC; and Jiming Cai, former Vice President of Sichuan Institute of Atomic Energy. The company is located in Western Airport Development District, Shuangliu, Chengdu, with an area of 71 Are, registered capital of 32.83 million CNY, and total investment of 300 million CNY. The project is listed as "Annual Key Investment Projects of Sichuan Province and Chengdu City in 2017, 2018 and 2019". At present, the company has over 80 employees, with more than 60 R&D specialists, including 1 academician of Chinese Academy of Engineering, 2 experts of Thousand Talent Project, 2 academic and technical leaders from Sichuan province, 10 researchers (associate researchers), and more than 20 people with middle or senior titles. Among them, there are 6 PhDs and over 30 graduates. The proportion of R&D staff has reached 70%, making CNRT the most innovative technology enterprise in the radiopharmaceutical industry in China.

Zhongbo Ruikang focuses on the research and development of domestic tools in the field of cell and gene therapy, mainly to assist customers in realizing the "continuous, closed, disposable, consistent, scalable, automated, modular, and medical deviceization of cell preparation industrialization.

Shanghai Electric Group Corp is a Chinese company specializing in the design, development, and manufacturing of thermal, nuclear, and wind power equipment. They provide a wide range of products including gas turbines, transmission and distribution equipment, elevators, machine tools, refrigeration compressors, environmental protection equipment, automation products, rail transportation equipment, machine parts, generators, and more. With a focus on power generation and infrastructure, Shanghai Electric Group Corp plays a significant role in China's energy sector and transportation industry.

Care Medical is a membrane science platform that focuses on blood purification and biopharmaceuticals.

Media Center is a technology-based corporation that uses technological innovation to boost industrial upgrading. It enables biotechnology and the bioindustry, the employs automation, artificial intelligence, big data, and industrial Internet technologies. Robot scientists free human scientists' hands, unleash their creativity, and raise the time and life value of mental workers, intelligent parallel bioreactors accelerate the R&D cycle, save laboratory space, and reduce R&D costs.

Zhongbo Ruikang focuses on the research and development of domestic tools in the field of cell and gene therapy, mainly to assist customers in realizing the "continuous, closed, disposable, consistent, scalable, automated, modular, and medical deviceization of cell preparation industrialization.

Dakang Medical operates a network of independent medical facilities specializing in blood purification services for kidney disease. The company focuses on providing advanced treatments such as hemodialysis, hemofiltration, and peritoneal dialysis, utilizing state-of-the-art medical technology. Dakang Medical emphasizes a patient-centered approach, aiming to create a warm and supportive environment to enhance the treatment experience for individuals suffering from nephropathy. In addition to its clinical services, Dakang Medical is involved in medical investment and the management of medical institutions, as well as offering brand operation services within the healthcare sector.

Xingsai Bio is a developer of single-cell analysis instruments and supporting reagents and consumables.

Maibang Bio provides biomedical process solutions such as R&D and production, customized medium optimization and development services, and liquid medium production. Their cell-culture medium companies might benefit from product performance and optimization development services. Maibang Bio focuses on the development and production of high-end chemically defined media products, the optimized development of customized media services, large-scale dry powder/liquid medium production, and other comprehensive biomedical process solutions.

Nuoyuan Medical Devices is a developer of high-end medical technologies that specializes in precision tumor surgery and treatment. The company aims to enhance clinical outcomes while optimizing the use of medical resources and increasing the efficiency of healthcare professionals. By focusing on innovative solutions in the field of oncology, Nuoyuan Medical Devices contributes to advancements in surgical procedures and treatment methodologies, ultimately improving patient care.

RzonTech is a provider of industrial software products, data services, and overall solutions.

Matrixtime Robotics is a technology company based in Hongqiao, China, specializing in deep learning and robot vision technology. Founded in 2018, the company focuses on developing advanced artificial intelligence systems and complex machine vision products tailored for high-end manufacturing. Matrixtime's offerings include solutions for defect detection, item picking and sorting, and various industrial tasks, empowering factories and manufacturers to enhance production efficiency and minimize quality assurance costs. The company serves a range of industries, including semiconductor manufacturing, photovoltaic energy, automotive precision manufacturing, and unmanned ports, providing scene-oriented industrial AI products that support digital transformation in manufacturing processes.

Xgene Pharmaceutical Inc. is a pharmaceutical company founded in 2015 and based in the Cayman Islands. It focuses on developing small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors, with a particular emphasis on neurological disorders. As a late-clinical stage, venture-backed firm, Xgene utilizes proprietary linker technology to create novel, multimodal conjugated molecules. Its current programs are designed to enhance the efficacy and tolerability of pain medications, addressing unmet needs in the treatment of chronic pain and neurological conditions.

Chineo is a company specializing in the development and provision of immune cell therapies, particularly focusing on CAR-T treatments. The company is dedicated to researching and developing cell therapy products aimed at treating tumors and immune diseases. Chineo's work involves utilizing high-throughput gene sequencing (NGS) alongside CAR-T technologies and other advanced cell therapy methods. This approach enables medical practitioners to enhance the diagnosis and treatment of tumors through innovative therapies such as tumor infiltrating lymphocyte therapy (TIL).

Andisec is a company dedicated to the research and development of industrial network security technology, products, and services. It specializes in developing software designed specifically for industrial-scale network security. The company's offerings include solutions that identify and defend against cyber attacks, viruses, and other cybersecurity threats, thereby enabling industrial enterprises to operate more securely. Through its innovative approach, Andisec aims to enhance the safety and resilience of critical infrastructure in the face of evolving cyber threats.

Rimag is a prominent medical imaging service provider based in Shenzhen, China, founded in 2014. The company specializes in the operation of medical imaging centers and the development of relevant cloud technologies. Rimag offers a variety of imaging services, including MRI, CT, PET, X-ray, ultrasound, and mammography, catering to patients and healthcare consumers through its flagship imaging centers. In addition to its imaging services, Rimag is also involved in talent training, ensuring that the workforce is well-equipped to meet the demands of the healthcare industry. Through its comprehensive approach, Rimag aims to enhance the quality and accessibility of medical imaging services in China.

Shenzhen MicroApproach Medical Technology Co., Ltd. is a high-tech enterprise established in September 2015, with a focus on the research, manufacture, and commercialization of endovascular medical devices. The company specializes in the development of high-end interventional surgery consumables, including hydrophilic guide wires, ultra-smooth guide wires, and angiography catheter products. Recognized for its strong research and development capabilities, MicroApproach collaborates closely with prominent medical institutions such as Beijing Tiantan Hospital and the People's Liberation Army 301 Hospital. The company has earned accolades, including the designation of "Engineering Technology Center of Endovascular Medical Devices" from the Shenzhen Science and Technology Innovation Committee. MicroApproach adheres to a company culture centered on quality and innovation, aiming to provide superior intravascular intervention products to medical professionals and patients. To support large-scale production and standardized management, it has implemented a robust management system and established a state-of-the-art industrial production line for its medical devices.

Jiangsu Hualan New Pharmaceutical Material Co., Ltd. specializes in the development, manufacture, and distribution of pharmaceutical packaging materials, primarily serving the Asia-Pacific region. The company produces a variety of products, including butyl rubber stoppers for transfusion, lyophilized and sterile powder applications, blood collection systems, and various types of containers such as three-piece soft bags and plastic bottles. Additionally, Hualan offers components like butyl compound films and gaskets. Established in 1992 and based in Jiangyin, China, the company was formerly known as Jiangyin Lanling Bottle Stopper Co., Ltd. It focuses on providing high-quality packaging solutions that ensure the safety and efficacy of pharmaceutical products.

Hocermed is a provider of energy platforms for invasive surgery. They has established research and development bases. They creates a comprehensive system that supports research and development, quality control, production, sales, and service. They supplies products with minimally invasive surgical solutions to healthcare professionals. They also invasive surgical energy devices. They provides surgical products and services to surgeons.

Hangzhou Proprium Biotech Company Limited is engaged in the development, manufacture, and sale of biomedical products and diagnostic reagents focused on cancer and cardiovascular diseases. The company provides a range of cardiac markers for heart disease diagnosis, including NT-proBNP and cTnI, as well as cirrhosis markers for liver disease, such as Fibro-CHI diagnostic kits. Proprium also offers various diagnostic tools, including rapid immunoassay readers, colloidal gold kits, enzyme-linked immunosorbent assay kits, and polymerase chain reaction detection kits. Additionally, the company has developed a mobile application aimed at managing liver diseases. Established in 2010 and based in Hangzhou, China, Proprium is committed to enabling early disease detection for improved patient outcomes.

Allist Pharmaceuticals is a pharmaceutical company based in Shanghai that focuses on discovering, developing, and commercializing innovative medicines, particularly in the field of cancer treatment. The company is driven by the unmet clinical needs within the global pharmaceutical market and is committed to advancing long life through scientific and technological innovation. Allist Pharmaceuticals aims to create safe, effective, and inclusive drugs, holding independent intellectual property rights for its products.

Smartee Denti-Technology, established in 2004, specializes in developing and manufacturing invisible orthodontic systems. The company's flagship product, the Smartee aligner, combines 3D printing, CAD, and CAM technologies to accurately move teeth without the need for traditional braces. With over 23.6 million sets of aligners delivered worldwide, Smartee has a strong presence in China and serves global markets. The company employs over 1,700 people, including a medical team of over 380 professionals, and has obtained more than 500 patents. Smartee is recognized for its innovation and contributions to the Chinese invisible orthodontic industry, holding memberships in various industry associations and collaborations with renowned institutions like the University of North Carolina and China Aerospace.

Beijing Biostar Technologies, Ltd., established in 2002, is a biopharmaceutical company based in Beijing, China. It specializes in the development of anti-tumor chemotherapy biopharmaceutical molecules, with a focus on creating innovative small molecule chemical drugs for cancer treatment. The company was founded by a team of Chinese scientists led by Dr. Tang Li and Dr. Qiu Rongguo, who previously worked in the United States. Biostar Technologies pioneered the creation of new anti-cancer drugs based on epothilone in China and its technology is recognized as being at the international advanced level.

Rimag is a prominent medical imaging service provider based in Shenzhen, China, founded in 2014. The company specializes in the operation of medical imaging centers and the development of relevant cloud technologies. Rimag offers a variety of imaging services, including MRI, CT, PET, X-ray, ultrasound, and mammography, catering to patients and healthcare consumers through its flagship imaging centers. In addition to its imaging services, Rimag is also involved in talent training, ensuring that the workforce is well-equipped to meet the demands of the healthcare industry. Through its comprehensive approach, Rimag aims to enhance the quality and accessibility of medical imaging services in China.

PANDAINS is an automobile insurance platform.

Automobile insurance sales management platform.

PANDAINS is an automobile insurance platform.

ACROBiosystems Inc. is a biotechnology company specializing in the manufacture of recombinant proteins for applications in cancer immunotherapy and other therapeutic areas. Founded in 2013 and headquartered in Newark, Delaware, the company produces a wide array of products, including immune checkpoint proteins, FC receptor proteins, llama IgG FC fusion proteins, biomarkers, CD antigens, and GMP-grade cytokines. Additionally, ACROBiosystems offers pre-labeled proteins, such as biotinylated collections, and various assay kits designed for quantitative analysis and inhibitor screening. The company is focused on supporting the development of targeted therapeutic drugs by providing essential reagents and services, including those needed for the creation of biological drugs and emergency responses to health crises like SARS-CoV-2 variants.

Oranger Technology is a company that develops portable wearable medical devices aimed at treating chronic respiratory diseases, particularly sleep apnea. The company offers a range of chronic respiratory disease management services that facilitate remote diagnosis and treatment at home. By utilizing a cloud-based interactive platform, Oranger provides comprehensive medical services, including screening, diagnosis, clinical evaluation, personalized treatment, and follow-up examinations. This approach enables patients to effectively manage their conditions and engage in self-rehabilitation, improving their overall health and quality of life.

Boke Information Co., Ltd. specializes in the research and development of management software and provides management consultancy services in China. The company focuses on creating personalized software products that emphasize autonomous configuration, self-expansion, and maintenance. Boke also offers implementation and technology services tailored for enterprises, government, and community organizations. Its expertise extends to logistics management software, aimed at enhancing supply chain efficiency. By leveraging artificial intelligence and machine learning technologies, Boke develops innovative solutions that facilitate effective software deployment and lifecycle management. Through these services, the company assists clients in establishing comprehensive organizational frameworks and optimizing their operational processes.

Shanghai Genext Medical Technology Co., Ltd specializes in the transplantation industry in China, offering a range of products and services that support organ transplants. Founded in 2003 and based in Shanghai, the company provides transplantation drugs, medical instruments, and in-vitro diagnostics. Its offerings include immunosuppressants, organ preservation and immune function platforms, therapeutic drug monitoring equipment, and various operational accessories. By focusing on innovative medical technologies, Shanghai Genext aims to enhance organ preservation, assessment, and diagnostic capabilities, ultimately delivering reliable and cost-effective medical services to patients. The company addresses diverse transplant needs, including kidney, heart, lung, bone marrow, and cell transplants.

RenRenChe, founded in April 2014, operates as a consumer-to-consumer (C2C) auto transaction service platform specializing in both used and new car sales. The company offers a range of services, including free door-to-door car valuation, sales, and replacement. To ensure quality, RenRenChe has established rigorous testing standards and employs a team of professional appraisers, collaborating with the China Automobile Dealers Association to set national benchmarks for second-hand car testing. The platform provides significant after-sales guarantees, including a 14-day return policy and a one-year warranty on core components, thereby enhancing buyer confidence. RenRenChe has attracted considerable investment, securing significant funding from notable investors, which has facilitated its growth and technological development within the industry.